XML 47 R33.htm IDEA: XBRL DOCUMENT
v3.25.2

Shareholders’ Equity (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Schedule of Stock-based Compensation Expense | The Company recognized stock-based compensation expense as follows (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Subscriber related | $ | 19 |  |  | $ | 79 |  |  | $ | 88 |  |  | $ | 158 |
Sales and marketing | 2,151 |  |  | 4,670 |  |  | (1,050) |  |  | 9,377 |
Technology and development | 2,635 |  |  | 2,631 |  |  | 5,915 |  |  | 6,509 |
General and administrative | 3,451 |  |  | 2,928 |  |  | 6,767 |  |  | 7,241 |
Total stock-based compensation expense | $ | 8,256 |  |  | $ | 10,308 |  |  | $ | 11,720 |  |  | $ | 23,285 |
Schedule of of Stock Option Activity | A summary of time-based stock option activity for the six months ended June 30, 2025 is as follows (in thousands, except share and per share amounts):
| Number of Shares |  | Weighted Average Exercise Price |  | Total Intrinsic Value |  | Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2024 | 10,196,232 |  |  | $ | 6.13 |  |  | $ | 1,036 |  |  | 4.4
Exercised | (2,151,631) |  |  | $ | 1.31 |  |  |  |  |
Forfeited or expired | (300) |  |  | $ | 9.98 |  |  |  |  |
Outstanding as of June 30, 2025 | 8,044,301 |  |  | $ | 7.42 |  |  | $ | 3,480 |  |  | 4.1
Options vested and exercisable as of June 30, 2025 | 7,726,114 |  |  | $ | 7.66 |  |  | $ | 2,894 |  |  | 4.4
A summary of activity under the 2020 Plan for market and service-based stock options for the six months ended June 30, 2025 is as follows (in thousands, except share and per share amounts):
| Number of Shares |  | Weighted Average Exercise Price |  | Total Intrinsic Value |  | Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2024 | 4,453,297 |  |  | $ | 12.75 |  |  | $ | — |  |  | 2.7
Outstanding as of June 30, 2025 | 4,453,297 |  |  | $ | 12.75 |  |  | $ | — |  |  | 2.2
Options vested and exercisable as of June 30, 2025 | 3,994,964 |  |  | $ | 11.96 |  |  | $ | — |  |  | 2.1
Schedule of Nonvested Restricted Stock Units Activity | A summary of the Company’s time-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:
| Number of Shares |  | Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024 | 26,709,357 |  |  | $ | 2.47 |
Granted | 3,356,913 |  |  | $ | 1.50 |
Vested | (1,089,843) |  |  | $ | 3.15 |
Forfeited or expired | (1,503,652) |  |  | $ | 2.69 |
Unvested at June 30, 2025 | 27,472,775 |  |  | $ | 2.31 |
A summary of the Company’s performance-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:
| Number of Shares |  | Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024 | 3,031,828 |  |  | $ | 5.61 |
Granted | 1,263,273 |  |  | $ | 3.01 |
Unvested at June 30, 2025 | 4,295,101 |  |  | $ | 4.85 |
A summary of the Company’s market and service-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:
| Number of Shares |  | Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024 | — |  |  | $ | — |
Granted | 1,304,802 |  |  | $ | 2.81 |
Unvested at June 30, 2025 | 1,304,802 |  |  | $ | 2.81 |
Schedule of Outstanding Warrants | A summary of the Company’s outstanding warrants as of June 30, 2025, are presented below (in thousands, except number of shares and exercise price):
| Number of Shares |  | Weighted Average Exercise Price |  | Total Intrinsic Value |  | Weighted Average Remaining Contractual Life (Years) |
Outstanding as of December 31, 2024 | 166,670 |  |  | $ | 17.40 |  |  | $ | — |  |  | 7.6 |
Forfeited or expired | (3) |  |  | $ | 133,500.00 |  |  |  |  |  |
Outstanding as of June 30, 2025 | 166,667 |  |  | $ | 15.00 |  |  | $ | — |  |  | 7.1 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration